These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20563567)

  • 21. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.
    Nebert DW; Vesell ES
    Trends Pharmacol Sci; 2006 Nov; 27(11):580-6. PubMed ID: 17005258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data.
    Primorac D; Bach-Rojecky L; Vađunec D; Juginović A; Žunić K; Matišić V; Skelin A; Arsov B; Boban L; Erceg D; Ivkošić IE; Molnar V; Ćatić J; Mikula I; Boban L; Primorac L; Esquivel B; Donaldson M
    Pharmacogenomics; 2020 Jan; 21(2):141-156. PubMed ID: 31950879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized medicine presents challenges and opportunities.
    Levenson D
    Am J Med Genet A; 2010 Feb; 152A(2):vii-viii. PubMed ID: 20101704
    [No Abstract]   [Full Text] [Related]  

  • 25. Transforming the FDA in the age of personalized medicine-interview with Ray Woosley.
    Musgrave E
    Clin Transl Sci; 2008 May; 1(1):5. PubMed ID: 20443811
    [No Abstract]   [Full Text] [Related]  

  • 26. Personalized medicine: inevitable.
    Peña AS
    Rev Esp Enferm Dig; 2010 Oct; 102(10):573-6. PubMed ID: 21039064
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
    Pilotto A; Panza F; Seripa D
    Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in international pediatric pharmacology: a milestone meeting in Shanghai.
    MacLeod S; Peterson R; Wang Y; Li Z; Gui Y; Schaller J
    Paediatr Drugs; 2007; 9(4):215-8. PubMed ID: 17705560
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacogenetics and pharmacogenomics in the discovery and development of medicines.
    Roses AD
    Novartis Found Symp; 2000; 229():63-6; discussion 66-70. PubMed ID: 11084930
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenetics: The right drug for you.
    Drew L
    Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform.
    Sissung TM; English BC; Venzon D; Figg WD; Deeken JF
    Pharmacogenomics; 2010 Jan; 11(1):89-103. PubMed ID: 20017675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Mis)treating the pharmacogenetic incidentalome.
    Kohane IS
    Nat Rev Drug Discov; 2012 Feb; 11(2):89-90. PubMed ID: 22293554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.
    Mitropoulou C; Litinski V; Kabakchiev B; Rogers S; P Patrinos G
    Pharmacogenomics; 2020 Jul; 21(11):797-807. PubMed ID: 32635813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development.
    Denny JC; Van Driest SL; Wei WQ; Roden DM
    Clin Pharmacol Ther; 2018 Mar; 103(3):409-418. PubMed ID: 29171014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics and personalized medicine. Are expectations being met?
    Gervasini G
    Med Clin (Barc); 2019 May; 152(9):368-371. PubMed ID: 30611536
    [No Abstract]   [Full Text] [Related]  

  • 39. PG-path: Modeling and personalizing pharmacogenomics-based pathways.
    Hong JY; Kim JH
    PLoS One; 2020; 15(5):e0230950. PubMed ID: 32365122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics: improving drug and dose selection.
    Bhathena A; Spear BB
    Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.